Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 2 2Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Rectal Neoplasms 1HIV Infections 1Disease 1Colonic Polyps 1Colitis, Ulcerative 1Anus Neoplasms 1Adenoma 1

Interventions

Fluorouracil 87Leucovorin 78Oxaliplatin 77Irinotecan 76Bevacizumab 50Cetuximab 42Capecitabine 42Panitumumab 17Folfox protocol 16Floxuridine 11Chemotherapy, Adjuvant 11regorafenib 10IFL protocol 10Nivolumab 9Drug Therapy 9trifluridine tipiracil drug combination 8Surgical Procedures, Operative 8Neoadjuvant Therapy 8sargramostim 7pembrolizumab 7XELOX 7Specimen Handling 7Biopsy 7Trastuzumab 6Radiotherapy 6Magnetic Resonance Spectroscopy 6HMPL-013 6tislelizumab 5encorafenib 5Trifluridine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Colonic Neoplasms × Colonoscopy × Clear all
NCT07140679 2025-09-25

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Emory University

Phase 2 Recruiting
40 enrolled
Gastrointestinal

Colonic Neoplasms

NCT01549535 2016-11-25

Polyp Detection With The Peerscope Systemâ„¢

PeerMedical Ltd.

Phase 2 Completed
197 enrolled
Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡